Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1247763.RAFo28ck9I6VTja7pbCRzmMqHWBhq2OygqZ9B54KoGsJQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1247763.RAFo28ck9I6VTja7pbCRzmMqHWBhq2OygqZ9B54KoGsJQ130_assertion type Assertion NP1247763.RAFo28ck9I6VTja7pbCRzmMqHWBhq2OygqZ9B54KoGsJQ130_head.
- NP1247763.RAFo28ck9I6VTja7pbCRzmMqHWBhq2OygqZ9B54KoGsJQ130_assertion description "[Non-small cell lung cancer (NSCLC) carrying echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) rearrangements is hypersensitive to ALK inhibitors, including crizotinib and alectinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247763.RAFo28ck9I6VTja7pbCRzmMqHWBhq2OygqZ9B54KoGsJQ130_provenance.
- NP1247763.RAFo28ck9I6VTja7pbCRzmMqHWBhq2OygqZ9B54KoGsJQ130_assertion evidence source_evidence_literature NP1247763.RAFo28ck9I6VTja7pbCRzmMqHWBhq2OygqZ9B54KoGsJQ130_provenance.
- NP1247763.RAFo28ck9I6VTja7pbCRzmMqHWBhq2OygqZ9B54KoGsJQ130_assertion SIO_000772 25502629 NP1247763.RAFo28ck9I6VTja7pbCRzmMqHWBhq2OygqZ9B54KoGsJQ130_provenance.
- NP1247763.RAFo28ck9I6VTja7pbCRzmMqHWBhq2OygqZ9B54KoGsJQ130_assertion wasDerivedFrom befree-2016 NP1247763.RAFo28ck9I6VTja7pbCRzmMqHWBhq2OygqZ9B54KoGsJQ130_provenance.
- NP1247763.RAFo28ck9I6VTja7pbCRzmMqHWBhq2OygqZ9B54KoGsJQ130_assertion wasGeneratedBy ECO_0000203 NP1247763.RAFo28ck9I6VTja7pbCRzmMqHWBhq2OygqZ9B54KoGsJQ130_provenance.